Literature DB >> 12612425

Effect of TRX-liposomes size on their prolonged circulation in rats.

Kazuo Kawahara1, Arinobu Sekiguchi, Emiko Kiyoki, Tsutomu Ueda, Kyoko Shimamura, Yasuo Kurosaki, Shozo Miyaoka, Hiromitsu Okabe, Masaharu Miyajima, Junji Kimura.   

Abstract

Newly formulated cationic liposomes (TRX-liposomes) with four different mean diameters were injected into twelve male rats via the lateral tail vein in order to evaluate the effect of liposomal size on pharmacokinetic parameters. TRX-liposomes disappeared from the blood according to the one-compartment model and demonstrated maximum and minimum half-lives of ca. 14 h (mean diameter of 114.3 nm) and ca. 5 h (mean diameter of 285.9 nm), respectively. This prolonged half-life tended to decrease at the boundary of 114.3 nm mean diameter. The optimal size (114.3 nm) for prolonged circulation of TRX-liposomes was consistent with that of pegylated liposomes such as Doxil((R)), however, the half-life was different among these liposomes. The electric charge of the TRX-liposomal surface is assumed to be responsible for this difference. The results of the present study will be very useful in the design of long-circulating cationic liposomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612425     DOI: 10.1248/cpb.51.336

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Local and average gloss from flat-faced sodium chloride tablets.

Authors:  Mikko Juuti; Bert van Veen; Kai-Erik Peiponen; Jarkko Ketolainen; Valtteri Kalima; Raimo Silvennoinen; Tuula T Pakkanen
Journal:  AAPS PharmSciTech       Date:  2006-01-13       Impact factor: 3.246

2.  Evaluating the anticancer properties of liposomal copper in a nude xenograft mouse model of human prostate cancer: formulation, in vitro, in vivo, histology and tissue distribution studies.

Authors:  Yan Wang; San Zeng; Tien-Min Lin; Lisa Krugner-Higby; Doug Lyman; Dana Steffen; May P Xiong
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis.

Authors:  Katsumi Morimoto; Masayo Kondo; Kazuo Kawahara; Hideto Ushijima; Yasuhiko Tomino; Masaharu Miyajima; Junji Kimura
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

4.  Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo: challenges and prospects.

Authors:  Judith Jakoby; Felix Beuschlein; Susanne Mentz; Constanze Hantel; Regine Süss
Journal:  Oncotarget       Date:  2015-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.